Treatment of acute decompensated heart failure: Harmful effects of high doses of loop diuretics?

Cardiology

Volumn 113, Issue 1, 2009, Pages 9-11

  Andersen, Geir Øystein ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; BRAIN NATRIURETIC PEPTIDE; BUMETANIDE; ETACRYNIC ACID; FUROSEMIDE; INOTROPIC AGENT; LOOP DIURETIC AGENT; NITRATE; NORADRENALIN; TORASEMIDE; TROPONIN; VASODILATOR AGENT;

ACUTE DECOMPENSATED HEART FAILURE; ACUTE HEART FAILURE; CARDIOVASCULAR RISK; CHRONIC KIDNEY FAILURE; DISEASE REGISTRY; DIURESIS; DRUG DOSE COMPARISON; DRUG DOSE REGIMEN; DRUG MEGADOSE; ELECTROLYTE DISTURBANCE; FORWARD HEART FAILURE; HEART AFTERLOAD; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART OUTPUT; HEART PRELOAD; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HENLE LOOP; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; HYPOTENSION; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; LUNG CONGESTION; LUNG EDEMA; NON INSULIN DEPENDENT DIABETES MELLITUS; NORADRENALIN BLOOD LEVEL; NOTE; PREDICTION; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; URINARY EXCRETION; VEIN DILATATION;

HEART FAILURE; HUMANS; INFUSIONS, INTRAVENOUS; KIDNEY; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS; UNITED STATES;

EID: 53849084160     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000164148     Document Type: Note

References (15)

1. The task force on acute heart failure of the European Society of Cardiology: Executive summary of the guidelines on the diagnosis and treatment of acute heart failure. Eur Heart J 2005; 26: 384-416.
2. Jong P, Vowinckel E, Liu PP, Gong Y, Tu JV: Prognosis and determinants of survival in patients newly hospitalized for heart failure: a population-based study. Arch Intern Med 2002; 162: 1689-1694.
3. Heart Failure Society of America: Executive summary: HFSA 2006 comprehensive heart failure practice guideline. J Card Fail 2006; 12: 10-38.
4. Eshaghian S, Horwich TB, Fonarow GC: Relation of loop diuretic dose to mortality in advanced heart failure. Am J Cardiol 2006; 97: 1759-1764.
5. Lopatin M, Wynne J, Mills RM, Emerman CL; for the ADHERE Scientific Advisory Committee and Investigators: Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompen sated heart failure: insights from the ADHERE registry. Cardiology 2009;113: 12-19.
6. Fonarow GC, Heywood JT, Heidenreich PA, Lopatin M, Yancy CW: Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2007; 153: 1021-1028.
7. Nieminen MS, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola VP, Hochadel M, Komajda M, Lassus J, Lopez-Sendon JL, Ponikowski P, Tavazzi L: EuroHeart Failure Survey II (EHFSII): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J 2006; 27: 2725-2736.
8. Costanzo MR, Johannes RS, Pine M, Gupta V, Saltzberg M, Hay J, Yancy CW, Fonarow GC: The safety of intravenous diuretics alone versus diuretics plus parenteral vasoactive therapies in hospitalized patients with acutely decompensated heart failure: a propensity score and instrumental variable analysis using the acutely decompensated heart failure national registry (ADHERE) database. Am Heart J 2007; 154: 267-277.
9. Brater DC: Diuretic therapy. N Engl J Med 1998; 339: 387-395.
10. Andersen GØ, Øie E, Vinge LE, Yndestad A, Attramadal H, Skomedal T, Osnes JB: Increased expression and function of the myocardial Na-K-2Cl cotransporter in failing rat hearts. Basic Res Cardiol 2006; 101: 471-478.
11. Dormans TP, Pickkers P, Russel FG, Smits P: Vascular effects of loop diuretics. Cardiovasc Res 1996; 32: 988-997.
12. de Berrazueta JR, Gonzalez JP, de Mier I, Poveda JJ, Garcia-Unzueta MT: Vasodilatory action of loop diuretics: a plethysmography study of endothelial function in forearm arteries and dorsal hand veins in hypertensive patients and controls. J Cardiovasc Pharmacol 2007; 49: 90-95.
13. Cotter G, Metzkor E, Kaluski E, Faigenberg Z, Miller R, Simovitz A, Shaham O, Marghitay D, Koren M, Blatt A, Moshkovitz Y, Zaidenstein R, Golik A: Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. Lancet 1998; 351: 389-393.
14. Francis GS, Siegel RM, Goldsmith SR, Olivari MT, Levine TB, Cohn JN: Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis. Ann Intern Med 1985; 103: 1-6.
15. Cotter G, Metra M, Milo-Cotter O, Dittrich HC, Gheorghiade M: Fluid overload in acute heart failure: re-distribution and other mechanisms beyond fluid accumulation. Eur J Heart Fail 2008; 10: 165-169.